Bayer Claims It Settled About 300 Of These Cases While Another 1300 Lawsuits Were Filed From Mid-October 2014 To The End Of January 2015
SUMMARY: From this earlier article, “December 2014 YAZ / Yasmin Litigation Update: Still Over 2000 DVT And/Or PE Cases Not Settled According To Bayer’s Most Recent Financial Report”, we get these previous numbers:
- As of October 13, 2014, the number of claimants in the pending lawsuits and claims in the United States totaled about 4,000 (excluding claims already settled).
- As of October 13, 2014, Bayer had reached agreements, without admission of liability, to settle the claims of approximately 9,200 claimants in the U.S. for a total amount of about US$1.8 billion.
And from the PRODUCT-RELATED LITIGATION part of Bayer’s Annual Report 2014, we get these more recent numbers:
- As of January 31, 2015, the number of claimants in the pending lawsuits and claims in the United States totaled about 5,000 (excluding claims already settled).
- As of January 31, 2015, Bayer had reached agreements, without admission of liability, to settle approximately 9,500 claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) for a total amount of about US$1.9 billion.
While the Bayer DRSP birth control pills Beyaz and Safyral are not mentioned in this part of the Annual Report, we know lawsuits for women who developed blood clots, including some who died, have been filed against the drug company in addition to YAZ, Yasmin, Gianvi, and Ocella cases involving DVT and/or PE side effects.[Read this article in full at original source]
Strictly Confidential, No Obligation.